Free Trial
NASDAQ:TLSA

Tiziana Life Sciences (TLSA) Stock Price, News & Analysis

Tiziana Life Sciences logo
$1.49 -0.04 (-2.61%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$1.50 +0.01 (+0.34%)
As of 07/8/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tiziana Life Sciences Stock (NASDAQ:TLSA)

Key Stats

Today's Range
$1.43
$1.55
50-Day Range
$1.22
$1.78
52-Week Range
$0.63
$1.91
Volume
211,045 shs
Average Volume
474,548 shs
Market Capitalization
$174.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Tiziana Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

TLSA MarketRank™: 

Tiziana Life Sciences scored higher than 16% of companies evaluated by MarketBeat, and ranked 874th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Tiziana Life Sciences.

  • Percentage of Shares Shorted

    0.95% of the float of Tiziana Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Tiziana Life Sciences has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tiziana Life Sciences has recently decreased by 16.68%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Tiziana Life Sciences does not currently pay a dividend.

  • Dividend Growth

    Tiziana Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.95% of the float of Tiziana Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Tiziana Life Sciences has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tiziana Life Sciences has recently decreased by 16.68%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Tiziana Life Sciences this week, compared to 1 article on an average week.
  • Search Interest

    4 people have searched for TLSA on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Tiziana Life Sciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tiziana Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.82% of the stock of Tiziana Life Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Tiziana Life Sciences' insider trading history.
Receive TLSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tiziana Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

TLSA Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

TLSA Stock Analysis - Frequently Asked Questions

Tiziana Life Sciences' stock was trading at $0.6962 at the beginning of 2025. Since then, TLSA stock has increased by 114.0% and is now trading at $1.49.

Tiziana Life Sciences (TLSA) raised $10 million in an initial public offering on the week of November 19th 2018. The company issued 1,000,000 shares at $9.90 per share. Laidlaw & Company (UK) Ltd. served as the underwriter for the IPO.

Shares of TLSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tiziana Life Sciences investors own include NIO (NIO), Advanced Micro Devices (AMD), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Meta Platforms (META), Inovio Pharmaceuticals (INO) and Pfizer (PFE).

Company Calendar

Today
7/09/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TLSA
CIK
1723069
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
37.25

Miscellaneous

Free Float
70,319,000
Market Cap
$174.11 million
Optionable
Optionable
Beta
-0.05
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:TLSA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners